An international team, led by researchers at the Champalimaud Foundation (CF), has shown – for the first time in a realistic way – that it may be possible, in the future, to diagnose Parkinson’s disease (PD) years earlier, by scanning people’s brains with functional magnetic resonance imaging (fMRI). Although there are treatment options after diagnosis, there is no cure.  Therapies are continually improving — with ongoing research aiming to slow or even alter the course of the disease - investing in the research of methods that enable much earlier diagnosis is crucial.

The Champalimaud Foundation is honoured to welcome Nobel Laureate Ardem Patapoutian for a public lecture. Awarded the 2021 Nobel Prize in Physiology or Medicine alongside David Julius for their discoveries of receptors for temperature and touch, Professor Patapoutian will join us at the Main Auditorium to share insights from his research. 

Attendance is free, but registration is required via the Eventbrite page. 

On the upcoming May 12th at 5:30 PM, the Auditorium of the Champalimaud Foundation will host a landmark event: the public presentation of the Multidisciplinary Recommendations on the Clinical Use of Psychedelic Substances.

Chosen from over 200 applicants across Europe and associated countries, Veiga-Fernandes was one of just 32 scientists ultimately appointed as ERC Ambassadors. The final selection aimed to balance gender, seniority, and the representation of both current ERC grant holders and different countries. The 32 ambassadors represent 21 EU Member States and four Associated Countries – Israel, Norway, Turkey, and the United Kingdom – plus Switzerland.

The conference Moving Beyond, which took place at the Champalimaud Foundation on April 3 and 4, 2025, was organised to gather world scientific leaders in the field of “exercise oncology”.

During the two-day conference, we interviewed a series of invited speakers on the benefits of physical activity for cancer prevention and treatment and asked speakers to share some of the key scientific advances in exercise oncology.

Watch the video and hear what they had to say — we hope you enjoy it!

At the Champalimaud Colorectal Cancer Conference, last February, Gina Brown, from the Imperial College London, questioned the validity of the current staging strategy for colon cancer. Indeed, research shows that lymph nodes are not the main culprit in colon cancer spread, and can actually be a sign that the patient’s immune system is fighting back.